IP Library Granted Patent US 10,806,835
Granted Patent B2
US 10,806,835 · App. 15/891,294 · Granted Oct 20, 2020

Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities

Inventors: Randall P. Kelch (San Antonio, TX); Xiaolu Zheng (San Antonio, TX); Reuben Walter Edgar, Jr. (San Antonio, TX); Jonathan Paul Jaeb (Boerne, TX); Thomas Paul Lawhorn (Denham Springs, LA); Shannon C. Ingram (Bulverde, TX)
Assignee: KCI Licensing, Inc.
A61M1/0031A61M1/0023A61M1/0025A61M1/0027A61M1/0058A61M1/0088G01F23/14A61M2205/15A61M2205/33A61M2205/3303A61M2205/3327A61M2205/3331A61M2205/3337A61M2205/3344A61M2205/3379A61M2205/581
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,806,835
App. No.
15/891,294
Granted
Oct 20, 2020
Kind
B2
Abstract

A method of treating a tissue site is provided. The method includes applying a reduced pressure to a tissue site with a reduced pressure source. A source pressure is monitored at the reduced pressure source, and a differential pressure is determined between the source pressure and the desired tissue site pressure. If a blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a first maximum differential pressure. If no blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a second maximum differential pressure.

Claims (25)

1. Apparatus for detecting a blockage between a tissue site and a reduced-pressure source fluidly connected to the tissue site, comprising:

a sensing device configured to sense a source pressure (SP) corresponding to pressure provided by the reduced-pressure source and a tissue site pressure (TSP) corresponding to pressure at the tissue site; and

a processor coupled to the sensing device and configured to receive the source pressure (SP) and the tissue site pressure (TSP), the processor having a first input adapted to be set to a target pressure (TP) desired for therapy at the tissue site and a second input adapted to be set to a first maximum differential pressure (DP 1 ) above the target pressure (TP), the processor being configured to

monitor a differential pressure (DP) being the difference between the source pressure (SP) and the target pressure (TP),

determine if the differential pressure (DP) is greater than or equal to the first maximum differential pressure (DP 1 ) when the tissue site pressure (TSP) is less than the target pressure (TP), and

determine whether a change in the source pressure (SP) results in a blockage between the tissue site and the reduced-pressure source.

2. The apparatus according to claim 1 , wherein the processor is configured further to determine whether the change in the source pressure (SP) results in a directionally corresponding change in the tissue site pressure (TSP).

3. The apparatus according to claim 1 , wherein the processor is further configured to indicate a blockage is present if (i) the tissue-site pressure (TSP) is less than the target pressure (TP), (ii) the differential pressure (DP) is greater than or equal to the first maximum differential pressure (DP 1 ), and (iii) a change in the source pressure (SP) does not result in a directionally corresponding change in the tissue-site pressure (TSP).

4. The apparatus according to claim 3 , wherein the first maximum differential pressure (DP 1 ) is less than or equal to about 50 mm Hg.

5. The apparatus according to claim 3 , wherein the processor further comprises an alarm device to alert a user of the presence of a blockage between the reduced pressure source and the tissue site.

6. The apparatus according to claim 1 , wherein the processor is further configured to indicate a blockage is not present if (i) the tissue-site pressure (TSP) is less than the target pressure (TP), (ii) the differential pressure (DP) is greater than or equal to the first maximum differential pressure (DP 1 ), and (iii) a change in the source pressure (SP) does result in a directionally corresponding change in the tissue-site pressure (TSP) confirming no blockage between the reduced pressure source and the tissue site.

7. The apparatus according to claim 6 , wherein the first maximum differential pressure (DP 1 ) is less than or equal to about 50 mm Hg.

8. The apparatus according to claim 1 , wherein the processor is further configured to prevent the source pressure (SP) from increasing further if (i) the tissue-site pressure (TSP) is less than the target pressure (TP), (ii) the differential pressure (DP) is greater than or equal to the first maximum differential pressure (DP 1 ), and (iii) a change in the source pressure (SP) does not result in a directionally corresponding change in the tissue-site pressure (TSP) indicating a blockage between the reduced-pressure source and the tissue site.

9. The apparatus according to claim 8 , wherein the first maximum differential pressure (DP 1 ) is less than or equal to about 50 mm Hg.

10. The apparatus according to claim 8 , wherein the processor further comprises an alarm device to alert a user of the presence of a blockage between the reduced pressure source and the tissue site.

11. The apparatus according to claim 1 , wherein the processor is further configured to allow the source pressure (SP) to increase further if (i) the tissue-site pressure (TSP) is less than the target pressure (TP), (ii) the differential pressure (DP) is greater than or equal to the first maximum differential pressure (DP 1 ), and (iii) a change in the source pressure (SP) does result in a directionally corresponding change in the tissue-site pressure (TSP) indicating no blockage between the reduced pressure source and the tissue site.

12. The apparatus according to claim 11 , wherein the first maximum differential pressure (DP 1 ) is less than or equal to about 50 mm Hg.

13. The apparatus according to claim 1 , wherein the processor further comprises a third input adapted to be set as a second maximum differential pressure (DP 2 ) greater than the target pressure (TP).

14. The apparatus according to claim 13 , wherein the second maximum differential pressure (DP 2 ) is greater than the first maximum differential pressure (DP 1 ).

15. The apparatus according to claim 13 , wherein the first maximum differential pressure (DP 1 ) is less than or equal to about 50 mm Hg.

16. The apparatus according to claim 13 , wherein the second maximum differential pressure is less than or equal to about 100 mm Hg.

17. The apparatus according to claim 13 , wherein the processor is further configured to prevent the source pressure (SP) from increasing further if the differential pressure (DP) is greater than or equal to the second maximum differential pressure (DP 2 ).

18. The apparatus according to claim 13 , wherein the processor further comprises an alarm device to alert a user that the differential pressure (DP) is greater than or equal to the second maximum differential pressure (DP 2 ).

19. The apparatus according to claim 1 , wherein the apparatus further includes a second sensing device.

20. The apparatus according to claim 19 , further comprising a canister fluidly connected between the tissue site and the reduced pressure source, and wherein the second sensing device measures the source pressure (SP) at the canister corresponding to pressure provided by the reduced-pressure source.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066443/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2020
From: KELCH, RANDALL P.; ZHENG, XIAOLU; EDGAR, REUBEN W., JR.; JAEB, JONATHAN PAUL; LAWHORN, THOMAS PAUL; INGRAM, SHANNON C.
To: KCI LICENSING, INC.
Reel/Frame 051726/0764 →
Continuity (7)
Continuation 14485094 · Sep 12, 2014
Continuation 13687677 · Nov 28, 2012
Continuation 12824582 · Jun 28, 2010
Division 11903165 · Sep 19, 2007
Provisional Application 60849138 · Oct 2, 2006
Provisional Application 60845993 · Sep 19, 2006
Related Publication 20180168916A1 · Jun 21, 2018
Cited By (1)
US 12,370,300